Early synaptic dysfunction in Parkinson's disease: Insights from animal models |
| |
| Authors: | Giuseppina Martella PhD Marta Maltese PhD Barbara Picconi PhD Paolo Calabresi MD Antonio Pisani MD PhD |
| |
| Affiliation: | 1. Department of Systems Medicine, University of Rome “Tor Vergata”, Rome, Italy;2. Fondazione Santa Lucia, IRCCS, Rome, Italy;3. Section of Neurology, Department of Medicine, University of Perugia, Perugia, Italy |
| |
| Abstract: | ![]()
The appearance of motor manifestations in Parkinson's disease (PD) is invariably linked to degeneration of nigral dopaminergic neurons of the substantia nigra pars compacta. Traditional views on PD neuropathology have been grounded in the assumption that the prime event of neurodegeneration involves neuronal cell bodies with the accumulation of metabolic products. However, this view has recently been challenged by both clinical and experimental evidence. Neuropathological studies in human brain samples and both in vivo and in vitro models support the hypothesis that nigrostriatal synapses may indeed be affected at the earliest stages of the neurodegenerative process. The mechanisms leading to either structural or functional synaptic dysfunction are starting to be elucidated and include dysregulation of axonal transport, impairment of the exocytosis and endocytosis machinery, altered intracellular trafficking, and loss of corticostriatal synaptic plasticity. The aim of this review is to try to integrate different lines of evidence from both pathogenic and genetic animal models that, to different extents, suggest that early synaptic impairment may represent the key event in PD pathogenesis. Understanding the molecular and cellular events underlying such synaptopathy is a fundamental step toward developing specific biomarkers of early dopaminergic dysfunction and, more importantly, designing novel therapies targeting the synaptic apparatus of selective, vulnerable synapses. © 2016 International Parkinson and Movement Disorder Society |
| |
| Keywords: | synaptopathy Parkinson's disease substantia nigra presymptomatic stage |
|
|
